BABYLYTE ORAL SOLUTION 240ML

Benefits & Uses

Primary Benefit

Restores fluids and electrolytes lost during diarrhea, vomiting, and dehydration in infants and children.

Health Claims

Restores fluid and electrolyte balance lost due to diarrhea and vomiting; prevents and treats mild to moderate dehydration in infants and children; WHO-endorsed oral rehydration therapy approach.

Common Deficiency Symptoms

Dehydration signs: dry mouth, decreased urine output, sunken eyes, lethargy, irritability, rapid heartbeat, decreased skin turgor. Electrolyte imbalance: muscle cramps, weakness.

Target Population

Infants and children experiencing mild to moderate dehydration due to acute diarrhea, vomiting, excessive sweating, or fever.

Scientific Evidence Level

Strong

Onset Timeline

Rehydration effects begin within 1-2 hours of administration; clinical improvement in dehydration signs typically within 4-6 hours.

Usage & Dosage

Suggested Use

Administer orally in small, frequent sips using the measuring cup or oral syringe provided. Do not dilute with water or other fluids. If vomiting occurs, pause for 10 minutes and restart at a slower rate.

Serving Size

As directed by physician or pharmacist based on child's weight and dehydration severity

Servings Per Container

Variable depending on prescribed volume per dose

Best Time to Take

Any time - administer continuously during episodes of diarrhea or vomiting until rehydration is achieved

Recommended Daily Intake

Mild dehydration: 50 mL/kg over 4 hours. Moderate dehydration: 100 mL/kg over 4 hours. For ongoing losses: 50-100 mL per loose stool for children under 2 years, 100-200 mL per loose stool for children over 2 years.

Upper Tolerable Limit

Volume should not exceed fluid requirements calculated by body weight; excess administration may cause hypernatremia or fluid overload.

Absorption Enhancers

Glucose (dextrose) actively facilitates sodium and water absorption via the sodium-glucose cotransporter (SGLT1) in the small intestine.

Absorption Inhibitors

Diluting the solution with water or other fluids alters the osmolarity and reduces efficacy; concurrent use of hyperosmolar juices or sodas impairs rehydration.

Side Effects

Possible Side Effects

Generally well-tolerated at recommended doses. If eyelids become puffy, stop the solution and give plain water. Excessive intake may cause vomiting, hypernatremia, or hyperkalemia.

Toxicity Risk

Low

Upper Tolerable Limit

Volume should not exceed fluid requirements calculated by body weight; excess administration may cause hypernatremia or fluid overload.

Safety & Warnings

Contraindications

Severe dehydration or shock requiring intravenous rehydration; intractable or persistent vomiting or inability to drink (e.g., altered consciousness) preventing oral intake; intestinal obstruction or ileus; anuria or oliguria or severe renal impairment; glucose-galactose malabsorption.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Safe

Children Suitability

Designed for infants and children; suitable from birth under medical supervision. Consult a physician for neonates under 1 month.

Interactions

Medication Interactions

No clinically significant drug interactions at recommended doses; use with caution in children on potassium-sparing diuretics or ACE inhibitors due to potassium content.

Supplement Interactions

Avoid concurrent administration of hyperosmolar oral supplements or high-sugar drinks that may worsen osmotic diarrhea.

Synergistic Nutrients

Zinc supplementation (10-20 mg/day for 10-14 days) is recommended alongside oral rehydration therapy to reduce the duration and severity of diarrhea in children.

Special Populations

Target Population

Infants and children experiencing mild to moderate dehydration due to acute diarrhea, vomiting, excessive sweating, or fever.

Children Suitability

Designed for infants and children; suitable from birth under medical supervision. Consult a physician for neonates under 1 month.

Pregnancy Safety

Consult Doctor

Breastfeeding Safety

Safe

Storage & Patient Advice

SFDA Storage Conditions

store below 25°c

Storage Conditions

Store below 25°C. Keep away from direct sunlight and out of reach of children. After opening, refrigerate and discard any unused solution after 24 hours.

Patient Counseling

Administer in small, frequent sips to minimize vomiting. Do not dilute or mix with water, juice, or milk. Continue breastfeeding or age-appropriate feeding alongside the solution. Do not substitute with soft drinks, sports drinks, or fruit juices. Store the opened bottle in the refrigerator and discard any unused portion after 24 hours. Seek immediate medical attention if signs of severe dehydration appear (no urine for 8+ hours, sunken fontanelle, no tears, lethargy), or if there is bloody diarrhea or persistent high fever.

Science & Evidence

Bioavailability Form

Oral rehydration solution - electrolytes are in ionic form (sodium, potassium, chloride, citrate) providing immediate absorption via sodium-glucose co-transport mechanism (SGLT1) in the intestinal mucosa

Water or Fat Soluble

Water-soluble

Scientific Evidence Level

Strong

Onset Timeline

Rehydration effects begin within 1-2 hours of administration; clinical improvement in dehydration signs typically within 4-6 hours.

Food Sources

Not applicable - this is a formulated medical oral rehydration solution; electrolytes are naturally found in bananas (potassium), table salt (sodium), and citrus fruits (citrate).

Product Information

Supplement Type

Combination

Certification

SFDA registered (Registration No. 2107222328); manufactured under GMP by Pharmaceutical Solution Industries (PSI), Saudi Arabia.

Suitable for Vegetarians

Yes

Suitable for Vegans

Yes

Age Range

0-12 years

Flavor

Unflavored

Sugar Content

2.75g per 100mL